Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
Primary Immunodeficiencies and Cancers Publisher



Hedayat M1 ; Alherz W2 ; Aghamohammadi A3 ; Nichols KE4 ; Rezaei N5, 6
Authors

Source: Cancer Immunology: A Translational Medicine Context Published:2015


Abstract

Primary immunodeficiencies (PIDs) comprise a heterogeneous group of genetic disorders, predisposing to frequent and severe infections, autoimmunity, and cancer. In recent years, the tendency to develop cancers has increased in parallel with improved life expectancy, largely due to effective immunoglobulin replacement and other supportive therapies. The overall risk for developing malignancies in children with PIDs is 4a€”25%, with lymphomas representing up to 60% of cancers. Defective immunosurveillance mechanisms and infection with oncogenic viruses have significant contributory roles in many cases. In this chapter, we review our understanding of the spectrum and pathogenesis of malignancies in the context of immunodeficiency syndromes, with emphasis on the epidemiologic data, clinical patterns, and potential importance of cancer screening for patients with specific PIDs. © Springer-Verlag Berlin Heidelberg 2015.
1. Inborn Errors of Immunity and Cancers, Cancer Immunology: A Translational Medicine Context# Second Edition (2020)
3. Common Presentations and Diagnostic Approaches, Stiehm's Immune Deficiencies: Inborn Errors of Immunity (2020)
Experts (# of related papers)
Other Related Docs
8. Congenital Neutropenia and Primary Immunodeficiency Diseases, Critical Reviews in Oncology/Hematology (2019)
13. Pulmonary Manifestations of Predominantly Antibody Deficiencies, Pulmonary Manifestations of Primary Immunodeficiency Diseases (2018)
16. Autoimmunity in Patients With Selective Iga Deficiency, Journal of Investigational Allergology and Clinical Immunology (2015)
20. Primary Immunodeficiency and Thrombocytopenia, International Reviews of Immunology (2022)